Quotient

Quotient is a commercial-stage diagnostics company primarily engaged in reducing healthcare costs and improving patient care through the development and commercialization of tests for blood grouping and serological disease screening, commonly referred to as transfusion diagnostics. The company's flagship product, MosaiQ™, is Quotient's next-generation automated platform for blood grouping and donor disease screening, representing a groundbreaking testing platform designed to meet the current and emerging needs of the $3.4 billion global transfusion diagnostics market.